IBM Attempts To Divest Watson Health This Time For Over $1B - IBM (NYSE:IBM)

International Business Machines Corp (NYSE:IBM) revived its sale process for IBM Watson Health, Axios reports.
IBM looks to procure over $1 billion from the sale. IBM spent over $4 billion to build Watson Health via acquisitions.
Watson Health now includes health care data and analytics business Truven Health Analytics, population health company Phytel, and medical imaging business Merge Healthcare.
IBM first explored a sale of the division in early 2021.
Price Action: IBM shares traded higher by 2.71% at $141.75 on the last check Wednesday.

To add Benzinga News as your preferred source on Google, click here.